White House seeks expanded control over US medical research funding

The White House is moving to centralize authority over medical research funding, a shift that could alter how agencies like NIH allocate grants. The scope and mechanism remain unspecified, but the move signals a policy pivot toward executive oversight of scientific priorities. This matters because it could reshape US biomedical research direction and trigger pushback from academic and scientific communities.